India’s pharmaceutical sector is expected to see revenue growth accelerate to 11-13% this fiscal from 8% last fiscal, supported by stronger exports and firmer domestic demand, according to Crisil Ratings. However, the improvement in revenue is unlikely to translate fully into earnings as higher raw material, energy and freight costs are expected to put pressure […]